HealthFab raises Rs 20 crore in Series A funding from Atomic Capital
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer
The initiative pairs consumer engagement with a public health message about prevention and early detection
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
The company posted revenue of €1,267 million, up 6% on a constant currency basis
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
Subscribe To Our Newsletter & Stay Updated